SOUTH SAN FRANCISCO, Calif., Sept. 3, 2019 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc. ("Satsuma"), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine, today announced that it has commenced an underwritten initial public offering of up to 5,000,000 shares of its common stock. All

FOSTER CITY, Calif., Sept. 3, 2019 /PRNewswire/ -- SutroVax, Inc., a biopharmaceutical company dedicated to the development of best-in-class conjugate vaccines and novel complex antigen-based vaccin

FREMONT, Calif., Sept. 3, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with cardiorenal diseases, today reported positive results from AMPLIFY, a pivotal Phase 3 study of tenapanor in combination with phosphate binders in patients with chronic

VALENCIA, Calif., Sept. 3, 2019 /PRNewswire/ -- Bioness, Inc., the leading provider of advanced, clinically supported medical devices for the treatment of chronic pain of peripheral nerve origin, is attending the 49th International Continence Society (ICS) Annual Meeting in Gothenburg, Sweden from 3-6 September

EUGENE, Ore., Sept. 3, 2019 /PRNewswire/ -- The Health & Safety Institute (HSI) today announces the closing of its acquisition by Waud Capital Partners from the Riverside Company. Chief Executive Officer Chad Birckelbaw and the current management team will continue to lead HSI.

BRIDGEWATER, N.J., Sept. 3, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following investor conferences:The H.C. Wainwright 21st Annual Global Investment

WALTHAM, Mass., Sept. 3, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc., the world leader in serving science, announces its support of Sepsis Awareness Month to drive awareness around sepsis, a complex clinical syndrome and a leading cause of death globally.1Throughout the month of September, supporters are encouraged to join together to raise sepsi

SAN JOSE, Calif., Sept. 3, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entere

ISFIYA, Israel, Sept. 3, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan® System, the first and only preparation-free ingestible scanning capsule based system for the prevention of colorectal cancer through the detec

CAESAREA, Israel, Sept. 3, 2019 /PRNewswire/ -- IceCure Medical Ltd. (TASE: ICCM), developer of the next generation cryoablation technology to treat malignant and benign tumors by freezing without the need for surgery, announced today an exclusive distribution agreement with leading global medical company, Terumo Corporation (Tokyo: 4543,